XKRX:318010 (Korea (the Republic of))
Â
Ordinary Shares
â‚©
3,390
+10 (+0.3%)
Mar 31
What is a stock summary page? Click here for an overview.
Business Description
Pharmsville Co Ltd
ISIN : KR7318010006
Share Class Description:
XKRX:318010: Ordinary SharesCompare
Compare
Traded in other countries / regions
318010.Korea Index Membership
KOSDAQ Composite Index IPO Date
2019-10-21Description
Pharmsville Co Ltd is a South Korea based company engaged in providing health-related drugs and products. It offers various products such as Prostate 365, Belgian Probiotics Diet Triplus, Mom Salido Gold, Devil's Cala Cleanse and Omega gummi among others.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1596.71 | |||||
| Equity-to-Asset | 0.96 | |||||
| Debt-to-EBITDA | 0.01 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 8.11 | |||||
| Beneish M-Score | -2.29 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -24.2 | |||||
| 3-Year EBITDA Growth Rate | -26.2 | |||||
| 3-Year EPS without NRI Growth Rate | -39.4 | |||||
| 3-Year Book Growth Rate | 3.4 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 49.02 | |||||
| 9-Day RSI | 40.55 | |||||
| 14-Day RSI | 39.51 | |||||
| 3-1 Month Momentum % | -2.54 | |||||
| 6-1 Month Momentum % | -29.4 | |||||
| 12-1 Month Momentum % | -48.59 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 19.04 | |||||
| Quick Ratio | 18.09 | |||||
| Cash Ratio | 17.4 | |||||
| Days Inventory | 148.8 | |||||
| Days Sales Outstanding | 23.41 | |||||
| Days Payable | 84.42 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.95 | |||||
| Dividend Payout Ratio | 0.51 | |||||
| Forward Dividend Yield % | 2.95 | |||||
| 5-Year Yield-on-Cost % | 1.81 | |||||
| 3-Year Average Share Buyback Ratio | 0.5 | |||||
| Shareholder Yield % | 13.71 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 62.9 | |||||
| Operating Margin % | -1.54 | |||||
| Net Margin % | 9.47 | |||||
| FCF Margin % | -2.7 | |||||
| ROE % | 2.48 | |||||
| ROA % | 2.26 | |||||
| ROIC % | -0.78 | |||||
| 3-Year ROIIC % | 311.99 | |||||
| ROC (Joel Greenblatt) % | 8.87 | |||||
| ROCE % | 2.05 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 16.53 | |||||
| PE Ratio without NRI | 17.2 | |||||
| Price-to-Owner-Earnings | 21.47 | |||||
| PS Ratio | 1.55 | |||||
| PB Ratio | 0.4 | |||||
| Price-to-Tangible-Book | 0.41 | |||||
| EV-to-EBIT | -8.44 | |||||
| EV-to-EBITDA | -6.62 | |||||
| EV-to-Revenue | -0.68 | |||||
| EV-to-FCF | 25.3 | |||||
| Price-to-GF-Value | 0.59 | |||||
| Price-to-Graham-Number | 0.56 | |||||
| Price-to-Net-Current-Asset-Value | 0.68 | |||||
| Price-to-Net-Cash | 0.75 | |||||
| Earnings Yield (Greenblatt) % | -11.84 | |||||
| FCF Yield % | -1.72 | |||||
| Forward Rate of Return (Yacktman) % | -12.66 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pharmsville Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 16,724.977 | ||
| EPS (TTM) (â‚©) | 205.1 | ||
| Beta | 0.2 | ||
| 3-Year Sharpe Ratio | -1.23 | ||
| 3-Year Sortino Ratio | -1.47 | ||
| Volatility % | 18.06 | ||
| 14-Day RSI | 39.51 | ||
| 14-Day ATR (â‚©) | 97.692928 | ||
| 20-Day SMA (â‚©) | 3489.5 | ||
| 12-1 Month Momentum % | -48.59 | ||
| 52-Week Range (â‚©) | 3275 - 7480 | ||
| Shares Outstanding (Mil) | 7.73 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Pharmsville Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Pharmsville Co Ltd Stock Events
| Event | Date | Price (â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Pharmsville Co Ltd Frequently Asked Questions
What is Pharmsville Co Ltd(XKRX:318010)'s stock price today?
The current price of XKRX:318010 is â‚©3390.00. The 52 week high of XKRX:318010 is â‚©7480.00 and 52 week low is â‚©3275.00.
When is next earnings date of Pharmsville Co Ltd(XKRX:318010)?
The next earnings date of Pharmsville Co Ltd(XKRX:318010) is .
Does Pharmsville Co Ltd(XKRX:318010) pay dividends? If so, how much?
The Dividend Yield %  of Pharmsville Co Ltd(XKRX:318010) is 2.95% (As of Today), Highest Dividend Payout Ratio of Pharmsville Co Ltd(XKRX:318010) was 0.62. The lowest was 0.14. And the median was 0.19. The  Forward Dividend Yield % of Pharmsville Co Ltd(XKRX:318010) is 2.95%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers